These insights suggest that while Aβ accumulation may initiate AD progression, other downstream processes, such as neuroinflammation and tau pathology, might be the main drivers of neurodegeneration (Long and Holtzman, 2019). This evidence concerns the gene MAPT and Alzheimer disease.